Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000985648 | SCV001134043 | likely pathogenic | not provided | 2018-09-20 | criteria provided, single submitter | clinical testing | Not found in the total gnomAD dataset, and the data is high quality (0/277192 chr). Found in at least one symptomatic patient. Assessment of experimental evidence suggests this variant results in abnormal protein function. |
Labcorp Genetics |
RCV001868341 | SCV002237374 | pathogenic | Biotinidase deficiency | 2023-11-17 | criteria provided, single submitter | clinical testing | This variant, c.594_596del, results in the deletion of 1 amino acid(s) of the BTD protein (p.Val199del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with biotinidase deficiency (PMID: 9396567, 25174816). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 587749). This variant disrupts the p.Val199 amino acid residue in BTD. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 12359137, 15060693, 25174816, 28498829). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |